Navigation Links
WellPoint Reports Fourth Quarter and Full Year 2007 Results
Date:1/23/2008

al and administrative

expense 1,686.3 1,830.1 (7.9%)

Total selling, general and

administrative expense 2,119.7 2,254.3 (6.0%)

Cost of drugs 96.7 100.7 (4.0%)

Interest expense 125.3 100.0 25.3%

Amortization of other intangible

assets 75.2 74.3 1.2%

Total expenses 14,238.6 13,296.0 7.1%

Income before income tax expense 1,322.8 1,283.8 3.0%

Income tax expense 463.7 482.7 (3.9%)

Net income $859.1 $801.1 7.2%

Net income per diluted share $1.51 $1.28 18.0%

Diluted shares 570.6 627.0 (9.0%)

Benefit expense as a percentage of

premiums 82.9% 81.0% 190 bp

Selling, general and administrative

expense as a percentage of total

operating revenue 13.8% 15.7% (190) bp

Income before income tax expense as a

percentage of total revenues 8.5% 8.8% (30) bp

WellPoint, Inc.

Consolidated Statements of Income

(In millions, except per share data)

Year Ended

December 31

2007 2006 Change

(Unaudited)

Revenues

Premiums $55,865.0 $51,971.9 7.5%

Administrative fees 3,674.6 3,595.4 2.2%

Other revenue
'/>"/>

SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine news :

1. WellPoint Announces Consumer Innovation Opportunity
2. WellPoint Appoints Brian A. Sassi as President and CEO of the Companys Consumer Business Unit
3. WellPoint Executive Mark Boxer Recognized as One of Computerworlds 2008 Premier 100 IT Leaders
4. WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts
5. WellPoint Highlights 2007 Accomplishments and Strong 2008 Outlook at Annual Investor Meeting
6. WellPoint Announces Appointment of John Cannon III as Executive Vice President & General Counsel
7. WellPoint Provides Support and Resources to Most Vulnerable California Residents
8. WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors
9. WellPoint Reports Third Quarter 2007 Results
10. WellPoint NextRx Receives National Leadership Award for Innovative Web Tool
11. Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...you need to know what triggers them, experts say ...If you are one of the 36 million Americans who suf...he United States that is free from pollen and othe...lergies don,t only happen in the spring, they can ...l, the most challenging cities to live in are Gree...
(Date:9/5/2008)...ewswire-USNewswire/ -- Speaker Nancy Pelosi,issued...ims of the "Stand,Up to Cancer" telethon, to be ai...son in our country who has not seen a loved one,su...cans annually, and each,year there are more than 1...ther to make eradicating the scourge of cancer a n...
(Date:9/5/2008)... /PRNewswire/ -- On Saturday, September 6, PARI,Re... Network show Today,s,Family as part of their "Bre...ing medical device company that provides patients,... and compressors that deliver needed,medications d...the lives of those affected by respiratory,disease...
(Date:9/5/2008)...ewswire-USNewswire/ -- As the general election,cam...tion of Independent,Business ( http://www.nfib.com...or a greater focus on the healthcare concerns of s...can conventions are over, NFIB,is asking both cand... faced,by small businesses as they further develop...
Breaking Medicine News(10 mins):Health News:No Place Safe From Allergies 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3
...omises to transfer unwanted weight from the hips t...sumer// watchdogs in the wake of recent unflatteri... that comes in the form of a drink, was accused in...aecological problems and doing nothing that it pro...
...by the researchers at the Imperial College London ...lergic responses than the others//. It was beli...t asthma and allergies. It was found that lab work...nts had fewer allergic reactions to the animals. ...
...ression may sink back into thinking patterns assoc...sses or sadness//, increasing their risk for relap...ntually relapse, according to background informati...ssion usually focuses on alleviating symptoms rath...
...ith fried eggs and the slogan 'This is your brain.... conventional //drug use among young Americans. Bu...nsive and more convenient ways to get high by usin...ink or in the bathroom of their homes – that are j...
Other Medicine News:Health News:Mild Sadness Provokes Depressive Thinking in Some Recovered Patients 2Health News:Inhalants: The New, Convenient High for Kids and Teens 2Health News:Inhalants: The New, Convenient High for Kids and Teens 3
(Date:9/4/2008)...a Announcements Remain on Schedule with Two Abstra...cal Data Release in November 2008, BRIDGEWATER, N...als,Inc., a specialty pharmaceutical company focu...ic disease, today announced the appointment of,Pet...rectors., Peter Garrambone,s career includes more...
(Date:9/3/2008)... says: Wrong Question Asked. Wrong Children Studie... /PRNewswire-USNewswire/ -- A Centers for Disease,...claims there is no link,between the MMR vaccine an...ys this study does nothing to dispel the growing p... raises several questions concerning design,and me...
(Date:9/3/2008)...American College of Rheumatology Research and Educ...ds Significant Advances in Detecting, ...ept. 3 /- For the first time during i...umatoid arthritis, the,American College of Rheumat...ng new information acquired from research funded b...
(Date:9/3/2008)... September is National Vascular Disease Awaren...ire/ -- Diffusion Pharmaceuticals,LLC, a clinical-... drugs,for the treatment of unmet medical needs, a...s in a Phase I/II clinical trial of its lead drug,...l, designated NCT00725881,on the clinicaltrials.go...
Breaking Medicine Technology:Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Saltwater crocodiles can find their way home 565 1Saltwater crocodiles can find their way home 565 2PIP A Revolution in Stress Management 2044 1PIP A Revolution in Stress Management 2044 2PIP A Revolution in Stress Management 2044 3Study expected to boost research for hearing and balance therapies 2042 1Study expected to boost research for hearing and balance therapies 2042 2Pennsylvania Game Commission Announces EHD Confirmed in Allegheny and Westmoreland Counties 2037 1Pennsylvania Game Commission Announces EHD Confirmed in Allegheny and Westmoreland Counties 2037 2Pennsylvania Game Commission Announces EHD Confirmed in Allegheny and Westmoreland Counties 2037 3
With its wide orifice tip, the Finntip Wide is designed especially for pipetting fragile cell suspensions and macromolecules like genomic DNA. This tip eliminates the mechanical shearing that causes
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
Volume range 1-5 ml. Designed for use with large laboratory vessels.
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
Medicine Products: